Common Contracts
2 similar License Agreement contracts by Zenas BioPharma, Inc.
LICENSE AGREEMENT by and between Zenas BioPharma, Inc. and BRISTOL-MYERS SQUIBB COMPANY Dated as of August 30, 2023License Agreement • August 22nd, 2024 • Zenas BioPharma, Inc. • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into on August 30, 2023 (the “Effective Date”), by and between Zenas BioPharma, Inc., a Delaware corporation (formerly known as Zenas BioPharma (Cayman) Limited, an exempted company organized under the laws of the Cayman Islands) (“Zenas”), and Bristol-Myers Squibb Company, a Delaware corporation (“Licensee”). Zenas and Licensee may each be referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENT by and between Zenas BioPharma, Inc. and BRISTOL-MYERS SQUIBB COMPANY Dated as of August 30, 2023License Agreement • January 25th, 2024 • Zenas BioPharma, Inc. • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into on August 30, 2023 (the “Effective Date”), by and between Zenas BioPharma, Inc., a Delaware corporation (formerly known as Zenas BioPharma (Cayman) Limited, an exempted company organized under the laws of the Cayman Islands) (“Zenas”), and Bristol-Myers Squibb Company, a Delaware corporation (“Licensee”). Zenas and Licensee may each be referred to herein individually as a “Party” and collectively as the “Parties.”
